Live Breaking News & Updates on Clerkenwell Health
Stay updated with breaking news from Clerkenwell health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clerkenwell Health is proud to announce the launch of its foundation course for Psychedelic-Assisted Therapy, a comprehensive 30-hour program that brings together leading experts in the field. ....
New 30-hour course brings together leading experts 1st May 2024, London – World-leading psychedelic clinical trials provider Clerkenwell Health is launching a new practitioner programme for healthcare professionals interested in psychedelic-assisted therapy. Clerkenwell Health’s Foundations Pro. ....
In an exciting collaboration, modern mental health company, Clerkenwell Health, and Beckley Psytech, a clinical-stage biotechnology company, have launched a phase 2a study aimed at investigating a potential breakthrough treatment for alcohol use disorder (AUD). ....
NOVEL PSYCHEDELIC COMPOUND TO BE TESTED FOR TREATMENT OF ALCOHOL USE DISORDER Novel psychedelic compound, combined with psychological support, will be explored as a potential new treatment for people living with alcohol use disorder (AUD).The trial uses Beckley Psytech’s lead candidate BPL-003, a short-du. ....
Incannex said that its Phase 2 Psi-GAD1 clinical trial of psilocybin in generalized anxiety disorder met its primary endpoint of demonstrating a large clinical effect in the psilocybin treatment group over the placebo group. ....